Company Profile

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE2252.6058.35 (+2.66 % )
PREV CLOSE (Rs.) 2194.25
OPEN PRICE (Rs.) 2204.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 150546
TODAY'S LOW / HIGH (Rs.)2179.70 2330.45
52 WK LOW / HIGH (Rs.)990 2330.45
NSE2252.80 56.85 (+2.59 % )
PREV CLOSE(Rs.) 2195.95
OPEN PRICE (Rs.) 2188.00
BID PRICE (QTY) 2252.80 (6 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3401862
TODAY'S LOW / HIGH(Rs.) 2180.95 2331.00
52 WK LOW / HIGH (Rs.)990 2331

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.03
Dividend Yield(%) 1.46
TTM EPS (Rs.) -5.33
P/E Ratio 0.00
Book Value (Rs.) 1001.74
Face Value (Rs.) 2
MCap (Rs. in Mn) 508047.55
Price/Earning (TTM) -581.29
Price/Sales (TTM) 27.84
Price/Book (MRQ) 2.25
PAT Margin (%) 3.43
ROCE (%) 6.41
Incorporation Year : 1947

Management Info :

Ajay Piramal - Chairman - Managing Director

Registered Office :

Address : Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone : 022 3802 3000/4000

Website : www.piramal.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
11Jun06-11-2021$Piramal Enterprises informs about payment of interest Piramal Enterprises informs

In compliance with Regulation 57 of the Listing Regulations, Piramal Enterprises has certified that the Company has made timely coupon payment for the Compulsorily Convertible Debentures bearing ISIN: INE140A08SY3 on 11th June 2021. Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

In compliance with Regulation 57 of the Listing Regulations, Pi..
09Jun06-09-2021$Piramal Enterprises’ arm, NITI Aayog launch home-care support for COVID patients in aspirational districts Piramal Enterprises’ arm,

Piramal Enterprises’ philanthropic arm -- Piramal Foundation along with government think-tank NITI Aayog have launched a three-month campaign to provide home-care support to 20 lakh Covid-19 patients, who are asymptomatic or have mild symptoms in 112 aspirational districts.

The new campaign 'Surakshit Hum Surakshit Tum Abhiyaanin' is expected to play a key role in aspirational district preparedness for managing nearly 70 percent of Covid cases at home, reducing pressure on the health system, and stemming the spread of fear amongst the people. Last year too, Piramal Foundation had run a campaign 'Surakshit Dada Dadi, Nana Nani Abhiyaan' under which it created awareness about wearing mask and using hand sanitisers one-on-one basis to 2.9 million elderly citizens in villages.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises’ philanthropic arm -- Piramal Foundation..
19May05-19-2021$Piramal Enterprises informs about analyst meet Piramal Enterprises informs

Piramal Enterprises has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst or Institutional Investor Meetings with the Company is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Piramal Enterprises has informed that pursuant to Regulation 30..
14May05-14-2021$Piramal Enterprises falls after reporting consolidated net loss of Rs 571 crore in Q4 Piramal Enterprises falls af

Piramal Enterprises is currently trading at Rs. 1646.35, down by 48.25 points or 2.85% from its previous closing of Rs. 1694.60 on the BSE.

The scrip opened at Rs. 1675.00 and has touched a high and low of Rs. 1686.20 and Rs. 1621.60 respectively. So far 22247 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2008.20 on 03-Mar-2021 and a 52 week low of Rs. 845.90 on 18-May-2020.

Last one week high and low of the scrip stood at Rs. 1723.35 and Rs. 1621.60 respectively. The current market cap of the company is Rs. 36682.68 crore.

The promoters holding in the company stood at 46.06%, while Institutions and Non-Institutions held 39.61% and 14.33% respectively.

Piramal Enterprises has reported results for fourth quarter and year ended March 31, 2021.

The company has reported net profit of Rs 78.71 crore for the quarter under review against net loss of Rs 484.28 crore for the same quarter in the previous year. Total income of the company decreased by 9.25% at Rs 516.63 crore for Q4FY21 as compared Rs 569.31 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net loss attributed to the owner at Rs 571.21 crore for the quarter under review against net loss of Rs 1,701.93 crore for the same quarter in the previous year. Total income of the company marginally decreased by 0.41% at Rs 3,565.98 crore for Q4FY21 as compared Rs 3,580.55 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a fall of 72.45% in its net profit at Rs 39.90 crore as compared to Rs 144.85 crore for the previous year. Total income of the company decreased by 28.29% at Rs 1,920.46 crore for year under review as compared to Rs 2,678.01 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported many fold jumps its net profit attributed to the owner at Rs 1,332.34 crore as compared to Rs 24.03 crore for the previous year. Total income of the company decreased by 2.85% at Rs 13,172.99 crore for year under review as compared to Rs 13,559.40 crore for year ended March 31, 2020.

Piramal Enterprises is currently trading at Rs. 1646.35, down b..
14May05-14-2021$Piramal Enterprises informs about independent auditor's reports Piramal Enterprises informs

In continuation to financial results for the quarter and financial year ended 31st March, 2021 which was filed with the stock exchanges after the Board Meeting held on 13th May, 2021, Piramal Enterprises has informed that it attached independent auditor's reports on audit of annual financial results (Standalone & Consolidated) and review of quarterly financial results with Unique Document Identification Number. This is also available on the Company's website at www.piramal.com.

The above information is a part of company’s filings submitted to BSE.

In continuation to financial results for the quarter and financ..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit787.1398.999999999997
Gross Profit 1292.2 -692.000000000003
Operating Profit 3175.412907.4
Net Sales 4935.918247
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 16323.30 (1.37%)
M.Cap ( in Cr)
34685.87
Dr. Reddys Lab (BSE)
 5451.20 (3.03%)
M.Cap ( in Cr)
90677.61
Alkem Laboratories (BSE)
 3195.75 (2.11%)
M.Cap ( in Cr)
38209.98
Caplin Point Lab (BSE)
 663.80 (7.98%)
M.Cap ( in Cr)
5021.17
Aurobindo Pharma (BSE)
 1010.25 (4.70%)
M.Cap ( in Cr)
59194.45
Shareholding Pattern More
FI/BANKS/INSURANCE 8.78 %
PROMOTERS 46.06 %
NON-INSTITUTION 14.33 %
MUTUAL FUNDS/UTI 1.4 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes